Levalbuterol hydrochloride/Ipratropium bromide

盐酸左沙丁胺醇/异丙托溴铵

Report date: 2026/03/04 20:01:44

Base Information

Drug NameLevalbuterol hydrochloride/Ipratropium bromide
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionBeta-2 adrenergic receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsBeta-2 adrenergic receptorMuscarinic acetylcholine receptor
Therapy Area/IndicationsBronchial Spasm
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBronchial Spasm
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A